Cargando…

BRD4: a general regulator of transcription elongation

Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Altendorfer, Elisabeth, Mochalova, Yelizaveta, Mayer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467588/
https://www.ncbi.nlm.nih.gov/pubmed/36047906
http://dx.doi.org/10.1080/21541264.2022.2108302
_version_ 1784788224449708032
author Altendorfer, Elisabeth
Mochalova, Yelizaveta
Mayer, Andreas
author_facet Altendorfer, Elisabeth
Mochalova, Yelizaveta
Mayer, Andreas
author_sort Altendorfer, Elisabeth
collection PubMed
description Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Drosophila. An increasing number of trans-acting factors have been linked to promoter-proximal pausing. Some factors help to establish the pause, whereas others are required for the release of Pol II into productive elongation. A dysfunction of this elongation control point leads to aberrant gene expression and can contribute to disease development. The BET bromodomain protein BRD4 has been implicated in elongation control. However, only recently direct BRD4-specific functions in Pol II transcription elongation have been uncovered. This mainly became possible with technological advances that allow selective and rapid ablation of BRD4 in cells along with the availability of approaches that capture the immediate consequences on nascent transcription. This review sheds light on the experimental breakthroughs that led to the emerging view of BRD4 as a general regulator of transcription elongation.
format Online
Article
Text
id pubmed-9467588
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-94675882022-09-13 BRD4: a general regulator of transcription elongation Altendorfer, Elisabeth Mochalova, Yelizaveta Mayer, Andreas Transcription Review Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Drosophila. An increasing number of trans-acting factors have been linked to promoter-proximal pausing. Some factors help to establish the pause, whereas others are required for the release of Pol II into productive elongation. A dysfunction of this elongation control point leads to aberrant gene expression and can contribute to disease development. The BET bromodomain protein BRD4 has been implicated in elongation control. However, only recently direct BRD4-specific functions in Pol II transcription elongation have been uncovered. This mainly became possible with technological advances that allow selective and rapid ablation of BRD4 in cells along with the availability of approaches that capture the immediate consequences on nascent transcription. This review sheds light on the experimental breakthroughs that led to the emerging view of BRD4 as a general regulator of transcription elongation. Taylor & Francis 2022-09-01 /pmc/articles/PMC9467588/ /pubmed/36047906 http://dx.doi.org/10.1080/21541264.2022.2108302 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Altendorfer, Elisabeth
Mochalova, Yelizaveta
Mayer, Andreas
BRD4: a general regulator of transcription elongation
title BRD4: a general regulator of transcription elongation
title_full BRD4: a general regulator of transcription elongation
title_fullStr BRD4: a general regulator of transcription elongation
title_full_unstemmed BRD4: a general regulator of transcription elongation
title_short BRD4: a general regulator of transcription elongation
title_sort brd4: a general regulator of transcription elongation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467588/
https://www.ncbi.nlm.nih.gov/pubmed/36047906
http://dx.doi.org/10.1080/21541264.2022.2108302
work_keys_str_mv AT altendorferelisabeth brd4ageneralregulatoroftranscriptionelongation
AT mochalovayelizaveta brd4ageneralregulatoroftranscriptionelongation
AT mayerandreas brd4ageneralregulatoroftranscriptionelongation